Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones.
Migliori GB, Langendam MW, D’Ambrosio L, Centis R, Blasi F, Huitric E, Manissero D, van der Werf MJ.
Eur Respir J 2012;40(4):814-22.
Abstract http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461345/